Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: A comparative study between methylprednisolone versus dexamethasone as an initial anti-inflammatory treatment of moderate COVID-19 pneumonia: an open-label randomized controlled trial

Original Submission
22 May 2024 Submitted Original manuscript
13 Jun 2024 Author responded Author comments - Yuda Sutherasan
17 Jun 2024 Reviewed Reviewer Report
27 Jun 2024 Reviewed Reviewer Report
22 Jul 2024 Author responded Author comments - Yuda Sutherasan
Resubmission - Version 2
13 Jun 2024 Submitted Manuscript version 2
27 Jul 2024 Reviewed Reviewer Report
8 Aug 2024 Author responded Author comments - Yuda Sutherasan
Resubmission - Version 3
8 Aug 2024 Submitted Manuscript version 3
25 Sep 2024 Reviewed Reviewer Report
27 Sep 2024 Reviewed Reviewer Report - Ronaldo C. Go
17 Oct 2024 Author responded Author comments - Yuda Sutherasan
Resubmission - Version 4
17 Oct 2024 Submitted Manuscript version 4
23 Oct 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
25 Oct 2024 Editorially accepted
11 Nov 2024 Article published 10.1186/s12890-024-03364-4

You can find further information about peer review here.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us